Keywords: knoll, ancrod, enters, pivotal, trial, stroke, anticoagulant

Knoll's Ancrod Enters Pivotal Trial For Stroke

Article | 24 June 1996

Print This

Knoll's ancrod, an anticoagulant derived from Malayan pit viper venom, is to enter a further Phase III trial in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in